These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38651960)

  • 1. [On the road to biological blood diagnosis of Alzheimer's disease?].
    Delaby C; Lehmann S
    Med Sci (Paris); 2024 Apr; 40(4):351-360. PubMed ID: 38651960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overview of the blood biomarkers in Alzheimer's disease: Promises and challenges.
    Delaby C; Hirtz C; Lehmann S
    Rev Neurol (Paris); 2023 Mar; 179(3):161-172. PubMed ID: 36371265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarkers of Alzheimer's disease: the present and the future.
    Lehmann S; Delaby C; Touchon J; Hirtz C; Gabelle A
    Rev Neurol (Paris); 2013 Oct; 169(10):719-23. PubMed ID: 24021316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying and validating biomarkers for Alzheimer's disease.
    Humpel C
    Trends Biotechnol; 2011 Jan; 29(1):26-32. PubMed ID: 20971518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluid biomarkers in Alzheimer's disease - current concepts.
    Rosén C; Hansson O; Blennow K; Zetterberg H
    Mol Neurodegener; 2013 Jun; 8():20. PubMed ID: 23800368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of amyloid beta peptides in body fluids for the diagnosis of alzheimer's disease: Where do we stand?
    Veerabhadrappa B; Delaby C; Hirtz C; Vialaret J; Alcolea D; Lleó A; Fortea J; Santosh MS; Choubey S; Lehmann S
    Crit Rev Clin Lab Sci; 2020 Mar; 57(2):99-113. PubMed ID: 31661652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laboratory biomarkers in Alzheimer's disease.
    Steinerman JR; Honig LS
    Curr Neurol Neurosci Rep; 2007 Sep; 7(5):381-7. PubMed ID: 17764627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluid Biomarkers in Clinical Trials for Alzheimer's Disease: Current and Future Application.
    Yang J; Jia L; Li Y; Qiu Q; Quan M; Jia J
    J Alzheimers Dis; 2021; 81(1):19-32. PubMed ID: 33749646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of fluid biomarkers in Alzheimer's Disease.
    Lewczuk P; Łukaszewicz-Zając M; Mroczko P; Kornhuber J
    Pharmacol Rep; 2020 Jun; 72(3):528-542. PubMed ID: 32385624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood-based high sensitivity measurements of beta-amyloid and phosphorylated tau as biomarkers of Alzheimer's disease: a focused review on recent advances.
    Chong JR; Ashton NJ; Karikari TK; Tanaka T; Schöll M; Zetterberg H; Blennow K; Chen CP; Lai MKP
    J Neurol Neurosurg Psychiatry; 2021 Nov; 92(11):1231-1241. PubMed ID: 34510001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid biomarkers for diagnosis of Alzheimer's disease: beta-amyloid(1-42), tau, phospho-tau-181 and total protein.
    Marksteiner J; Hinterhuber H; Humpel C
    Drugs Today (Barc); 2007 Jun; 43(6):423-31. PubMed ID: 17612711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Biomarkers in Alzheimer's disease].
    García-Ribas G; López-Sendón Moreno JL; García-Caldentey J
    Rev Neurol; 2014 Apr; 58(7):308-17. PubMed ID: 24677154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis of Alzheimer's disease utilizing amyloid and tau as fluid biomarkers.
    Lee JC; Kim SJ; Hong S; Kim Y
    Exp Mol Med; 2019 May; 51(5):1-10. PubMed ID: 31073121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers for Alzheimer's disease: current status and prospects for the future.
    Blennow K; Zetterberg H
    J Intern Med; 2018 Dec; 284(6):643-663. PubMed ID: 30051512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Biomarkers of Alzheimer disease].
    Rachel W; Grela A; Zyss T; Zieba A; Piekoszewski W
    Przegl Lek; 2014; 71(2):98-101. PubMed ID: 25016785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cerebrospinal fluid biomarkers of Alzheimer's disease in current clinical practice].
    Magnin E; Popp J
    Rev Med Suisse; 2016 Apr; 12(515):791-4. PubMed ID: 27276722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood-based biomarkers in Alzheimer's disease - moving towards a new era of diagnostics.
    Arslan B; Zetterberg H; Ashton NJ
    Clin Chem Lab Med; 2024 May; 62(6):1063-1069. PubMed ID: 38253262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarkers of mild cognitive impairment and Alzheimer's disease.
    Tang BL; Kumar R
    Ann Acad Med Singap; 2008 May; 37(5):406-10. PubMed ID: 18536828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cerebrospinal Fluid and Blood Biomarkers in Alzheimer's Disease].
    Yanagida K; Tagami S; Okochi M
    Brain Nerve; 2017 Jul; 69(7):825-833. PubMed ID: 28739997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum Fragments of Tau for the Differential Diagnosis of Alzheimer's Disease.
    Inekci D; Henriksen K; Linemann T; Karsdal MA; Habib A; Bisgaard C; Eriksen FB; Vilholm OJ
    Curr Alzheimer Res; 2015; 12(9):829-36. PubMed ID: 26159200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.